Will Medicaid Take More Than Its Fair Share Of Dual-Eligible Rebates?
Executive Summary
Industry concerns that states are sometimes obtaining Medicaid drug rebates that are disproportionate to drug expenditures are unlikely to be allayed by CMS' recent proposed rules on Medicaid drug reimbursement